{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:12:37Z","timestamp":1793887957015,"version":"4.8.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Top Curr Chem (Z)"],"DOI":"10.1007\/s41061-026-00557-9","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:39:02Z","timestamp":1780429142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in Ciprofloxacin Derivatives: Emerging Strategies to Combat Antimicrobial Resistance"],"prefix":"10.1007","volume":"384","author":[{"given":"Vishal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahbaz","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"3","key":"557_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.9734\/ijpr\/2023\/v12i3226","volume":"12","author":"GM Ikokwu","year":"2023","unstructured":"Ikokwu GM, Oseghale ID, Omoregie I, Ralph-Okhiria OH, Ighile EF (2023) Emerging trends in antimicrobial resistance and novel therapeutic strategies. Int J Pathog Res 12(3):10\u201326","journal-title":"Int J Pathog Res"},{"key":"557_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174151","volume":"903","author":"V Thakur","year":"2021","unstructured":"Thakur V, Uniyal A, Tiwari V (2021) A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance. Eur J Pharmacol 903:174151","journal-title":"Eur J Pharmacol"},{"key":"557_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.720726","volume":"12","author":"T Khare","year":"2021","unstructured":"Khare T, Anand U, Dey A, Assaraf YG, Chen ZS, Liu Z, Kumar V (2021) Exploring phytochemicals for combating antibiotic resistance in microbial pathogens. Front Pharmacol 12:720726","journal-title":"Front Pharmacol"},{"issue":"3","key":"557_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41570-023-00463-4","volume":"7","author":"A Frei","year":"2023","unstructured":"Frei A, Verderosa AD, Elliott AG, Zuegg J, Blaskovich MA (2023) Metals to combat antimicrobial resistance. Nat Rev Chem 7(3):202\u2013224","journal-title":"Nat Rev Chem"},{"key":"557_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00546","volume":"8","author":"D Sharma","year":"2017","unstructured":"Sharma D, Patel RP, Zaidi STR, Sarker MMR, Lean QY, Ming LC (2017) Interplay of the quality of ciprofloxacin and antibiotic resistance in developing countries. Front Pharmacol 8:546","journal-title":"Front Pharmacol"},{"issue":"3","key":"557_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030642","volume":"14","author":"JTCD Pontes","year":"2022","unstructured":"Pontes JTCD, Toledo Borges AB, Roque-Borda CA, Pavan FR (2022) Antimicrobial peptides as an alternative for the eradication of bacterial biofilms of multi-drug resistant bacteria. Pharmaceutics 14(3):642","journal-title":"Pharmaceutics"},{"issue":"10","key":"557_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101362","volume":"11","author":"M Irfan","year":"2022","unstructured":"Irfan M, Almotiri A, AlZeyadi ZA (2022) Antimicrobial resistance and its drivers\u2014a review. Antibiotics 11(10):1362","journal-title":"Antibiotics"},{"key":"557_CR8","doi-asserted-by":"crossref","unstructured":"Yayehrad AT, Wondie GB & Marew T (2022) Different nanotechnology approaches for ciprofloxacin delivery against multidrug-resistant microbes. Infect Drug Resistance 413\u2013426","DOI":"10.2147\/IDR.S348643"},{"issue":"05","key":"557_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.31782\/IJCRR.2021.13511","volume":"13","author":"S Ponnusankar","year":"2021","unstructured":"Ponnusankar S (2021) Need for the implementation of antibiotic policy in India: an overview. Int J Curr Res Rev 13(05):168","journal-title":"Int J Curr Res Rev"},{"issue":"1","key":"557_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pharmaceutics10010011","volume":"10","author":"M Kumar","year":"2018","unstructured":"Kumar M, Curtis A, Hoskins C (2018) Application of nanoparticle technologies in the combat against anti-microbial resistance. Pharmaceutics 10(1):11","journal-title":"Pharmaceutics"},{"issue":"4","key":"557_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3109\/14756360903373350","volume":"25","author":"PC Sharma","year":"2010","unstructured":"Sharma PC, Jain A, Jain S, Pahwa R, Yar MS (2010) Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects. J Enzyme Inhib Med Chem 25(4):577\u2013589","journal-title":"J Enzyme Inhib Med Chem"},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jinorgbio.2013.10.013","volume":"131","author":"P Fernandes","year":"2014","unstructured":"Fernandes P, Sousa I, Cunha-Silva L, Ferreira M, de Castro B, Pereira EF, Feio MJ, Gameiro P (2014) Synthesis, characterization and antibacterial studies of a copper (II) lomefloxacin ternary complex. J Inorg Biochem 131:21\u201329","journal-title":"J Inorg Biochem"},{"issue":"1","key":"557_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4155\/fmc.12.181","volume":"5","author":"W Castro","year":"2013","unstructured":"Castro W, Navarro M, Biot C (2013) Medicinal potential of ciprofloxacin and its derivatives. Future Med Chem 5(1):81\u201396","journal-title":"Future Med Chem"},{"issue":"1","key":"557_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/0255-0857.148374","volume":"33","author":"T Bharara","year":"2015","unstructured":"Bharara T, Bhalla P, Rawat D, Garg VK, Sardana K, Chakravarti A (2015) Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone. Indian J Med Microbiol 33(1):39\u201342","journal-title":"Indian J Med Microbiol"},{"key":"557_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1025633","volume":"10","author":"A Shariati","year":"2022","unstructured":"Shariati A, Arshadi M, Khosrojerdi MA, Abedinzadeh M, Ganjalishahi M, Maleki A, Heidary M, Khoshnood S (2022) The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Front Public Health 10:1025633","journal-title":"Front Public Health"},{"issue":"1","key":"557_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11030-024-10862-4","volume":"29","author":"V Sharma","year":"2025","unstructured":"Sharma V, Das R, Mehta DK, Sharma D, Aman S, Khan MU (2025) Quinolone scaffolds as potential drug candidates against infectious microbes: a review. Mol Divers 29(1):711\u2013737","journal-title":"Mol Divers"},{"key":"557_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116674","volume":"59","author":"V Sharma","year":"2022","unstructured":"Sharma V, Das R, Mehta DK, Gupta S, Venugopala KN, Mailavaram R, Nair AB, Shakya AK, Deb PK (2022) Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold. Bioorg Med Chem 59:116674","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"557_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1389557521666210112142136","volume":"22","author":"V Sharma","year":"2022","unstructured":"Sharma V, Das R, Mehta DK, Sharma D, Sahu RK (2022) Exploring quinolone scaffold: unravelling the chemistry of anticancer drug design. Mini Rev Med Chem 22(1):69\u201388","journal-title":"Mini Rev Med Chem"},{"issue":"16","key":"557_CR19","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2174\/1389557517666170510104954","volume":"17","author":"V Sharma","year":"2017","unstructured":"Sharma V, Kumar Mehta D, Das R (2017) Synthetic methods of quinoline derivatives as potent anticancer agents. Mini Rev Med Chem 17(16):1557\u20131572","journal-title":"Mini Rev Med Chem"},{"key":"557_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.563975","volume":"11","author":"M Imchen","year":"2020","unstructured":"Imchen M et\u00a0al (2020) Current trends in experimental and computational approaches to combat antimicrobial resistance. Front Genet 11:563975. https:\/\/doi.org\/10.3389\/fgene.2020.563975","journal-title":"Front Genet"},{"issue":"Suppl 2","key":"557_CR21","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1086\/428052","volume":"41","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 41(Suppl 2):S120\u2013S126. https:\/\/doi.org\/10.1086\/428052","journal-title":"Clin Infect Dis"},{"issue":"1","key":"557_CR22","volume":"2012","author":"A Dalhoff","year":"2012","unstructured":"Dalhoff A (2012) Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis 2012(1):976273","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"1","key":"557_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","volume":"1354","author":"DC Hooper","year":"2015","unstructured":"Hooper DC, Jacoby GA (2015) Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci 1354(1):12\u201331","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"557_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","volume":"22","author":"LS Redgrave","year":"2014","unstructured":"Redgrave LS, Sutton SB, Webber MA, Piddock LJ (2014) Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol 22(8):438\u2013445","journal-title":"Trends Microbiol"},{"issue":"8","key":"557_CR25","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/pharmaceutics14081749","volume":"14","author":"IA Lungu","year":"2022","unstructured":"Lungu IA, Moldovan OL, Biri\u0219 V, Rusu A (2022) Fluoroquinolones hybrid molecules as promising antibacterial agents in the fight against antibacterial resistance. Pharmaceutics 14(8):1749","journal-title":"Pharmaceutics"},{"key":"557_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s42250-025-01418-6","author":"V Sharma","year":"2025","unstructured":"Sharma V, Das R, Sharma D, Mehta DK (2025) Design, synthesis, and evaluation of novel quinolone-6-substituted-(1, 3, 4-thiadiazole) derivatives as antimicrobial and anti-inflammatory agents. Chem Afr. https:\/\/doi.org\/10.1007\/s42250-025-01418-6","journal-title":"Chem Afr"},{"issue":"3","key":"557_CR27","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s11030-024-10949-y","volume":"29","author":"V Sharma","year":"2025","unstructured":"Sharma V, Das R, Mehta DK, Sharma D (2025) Novel quinolone substituted 1, 3, 4-oxadiazole derivatives: design, synthesis, antimicrobial and anti-inflammatory potential. Mol Divers 29(3):1911\u20131928","journal-title":"Mol Divers"},{"issue":"5","key":"557_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202401936","volume":"22","author":"V Sharma","year":"2025","unstructured":"Sharma V, Saini M, Das R, Chauhan S, Sharma D, Mujwar S, Gupta S, Mehta DK (2025) Recent updates on antibacterial quinolones: green synthesis, mode of interaction and structure\u2013activity relationship. Chem Biodivers 22(5):e202401936","journal-title":"Chem Biodivers"},{"issue":"8","key":"557_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2174\/1573406418666220214085856","volume":"18","author":"M Saini","year":"2022","unstructured":"Saini M, Das R, Mehta DK, Chauhan S (2022) Styrylquinolines derivatives: SAR study and synthetic approaches. Med Chem 18(8):859\u2013870","journal-title":"Med Chem"},{"issue":"1","key":"557_CR30","volume":"2013","author":"R Bartzatt","year":"2013","unstructured":"Bartzatt R, Cirillo SL, Cirillo JD (2013) Antibacterial derivatives of ciprofloxacin to inhibit growth of necrotizing fasciitis associated penicillin resistant Escherichia coli. J Pharm 2013(1):517638","journal-title":"J Pharm"},{"issue":"9","key":"557_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094919","volume":"25","author":"V Khwaza","year":"2024","unstructured":"Khwaza V, Mlala S, Aderibigbe BA (2024) Advancements in synthetic strategies and biological effects of ciprofloxacin derivatives: a review. Int J Mol Sci 25(9):4919","journal-title":"Int J Mol Sci"},{"issue":"23","key":"557_CR32","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1080\/00397911.2016.1234622","volume":"46","author":"R Akhtar","year":"2016","unstructured":"Akhtar R, Yousaf M, Naqvi SAR, Irfan M, Zahoor AF, Hussain AI, Chatha SAS (2016) Synthesis of ciprofloxacin-based compounds: a review. Synth Commun 46(23):1849\u20131879","journal-title":"Synth Commun"},{"issue":"1","key":"557_CR33","doi-asserted-by":"publisher","first-page":"13827","DOI":"10.1038\/s41598-022-17993-4","volume":"12","author":"K Pedrood","year":"2022","unstructured":"Pedrood K, Azizian H, Montazer MN, Moazzam A, Asadi M, Montazeri H, Biglar M, Zamani M, Larijani B, Zomorodian K, Mohammadi-Khanaposhtani M, Irajie C, Amanlou M, Iraji A, Mahdavi M (2022) Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activity. Sci Rep 12(1):13827","journal-title":"Sci Rep"},{"key":"557_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jinorgbio.2012.02.003","volume":"110","author":"I Sousa","year":"2012","unstructured":"Sousa I, Claro V, Pereira JL, Amaral AL, Cunha-Silva L, De Castro B, Feio MJ, Pereira E, Gameiro P (2012) Synthesis, characterization and antibacterial studies of a copper (II) levofloxacin ternary complex. J Inorg Biochem 110:64\u201371","journal-title":"J Inorg Biochem"},{"key":"557_CR35","unstructured":"O\u2019Neill J (2016) Tackling drug-resistant infections globally: final report and recommendations."},{"key":"557_CR36","unstructured":"World Health Organization (2021) Antimicrobial resistance. WHO Fact Sheets."},{"issue":"4","key":"557_CR37","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. P T 40(4):277","journal-title":"P T"},{"issue":"10442","key":"557_CR38","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/S0140-6736(24)00876-6","volume":"403","author":"IN Okeke","year":"2024","unstructured":"Okeke IN, de Kraker ME, Van Boeckel TP, Kumar CK, Schmitt H, Gales AC, Laxminarayan R (2024) The scope of the antimicrobial resistance challenge. Lancet 403(10442):2426\u20132438","journal-title":"Lancet"},{"key":"557_CR39","doi-asserted-by":"crossref","unstructured":"Boerlin P & White DG (2013) Antimicrobial resistance and its epidemiology. Antimicrobial therapy in veterinary medicine 21\u201340","DOI":"10.1002\/9781118675014.ch3"},{"key":"557_CR40","doi-asserted-by":"crossref","unstructured":"Munita JM & Arias CA (2016) Mechanisms of antibiotic resistance. Virulence mechanisms of bacterial pathogens, 481\u2013511","DOI":"10.1128\/9781555819286.ch17"},{"key":"557_CR41","doi-asserted-by":"crossref","unstructured":"Ahmad M, Aduru SV, Smith RP, Zhao Z & Lopatkin AJ (2025) The role of bacterial metabolism in antimicrobial resistance. Nat Rev Microbiol 1\u201316","DOI":"10.1038\/s41579-025-01155-0"},{"issue":"6","key":"557_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2020.100971","volume":"66","author":"MA Abushaheen","year":"2020","unstructured":"Abushaheen MA, Fatani AJ, Alosaimi M, Mansy W, George M, Acharya S et\u00a0al (2020) Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon 66(6):100971","journal-title":"Dis Mon"},{"issue":"2","key":"557_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","volume":"49","author":"K Poole","year":"2005","unstructured":"Poole K (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49(2):479\u2013487","journal-title":"Antimicrob Agents Chemother"},{"key":"557_CR44","doi-asserted-by":"crossref","unstructured":"Kummerfeldt CE (2014) Raxibacumab: potential role in the treatment of inhalational anthrax. Infection and drug resistance, 101\u2013109","DOI":"10.2147\/IDR.S47305"},{"issue":"3","key":"557_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1056\/NEJMoa0907635","volume":"362","author":"I Lowy","year":"2010","unstructured":"Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD, Leney M, Sloan S, Hay CA, Ambrosino DM (2010) Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 362(3):197\u2013205","journal-title":"N Engl J Med"},{"issue":"7","key":"557_CR46","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1128\/AAC.01405-09","volume":"54","author":"M Serizawa","year":"2010","unstructured":"Serizawa M, Sekizuka T, Okutani A, Banno S, Sata T, Inoue S, Kuroda M (2010) Genomewide screening for novel genetic variations associated with ciprofloxacin resistance in Bacillus anthracis. Antimicrob Agents Chemother 54(7):2787\u20132792","journal-title":"Antimicrob Agents Chemother"},{"key":"557_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/hesc\/9780198866664.001.0001","volume-title":"An introduction to medicinal chemistry","author":"GL Patrick","year":"2023","unstructured":"Patrick GL (2023) An introduction to medicinal chemistry. Oxford University Press"},{"key":"557_CR48","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1016\/j.ejmech.2011.08.030","volume":"46","author":"AAM Abdel-Aziza","year":"2011","unstructured":"Abdel-Aziza AAM, Asiric YA, Al-Agamy MHM (2011) Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study. Eur J Med Chem 46:5487\u20135497. https:\/\/doi.org\/10.1016\/j.ejmech.2011.08.030","journal-title":"Eur J Med Chem"},{"issue":"6","key":"557_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9061158","volume":"9","author":"KE Knoll","year":"2021","unstructured":"Knoll KE, Lindeque Z, Adeniji AA, Oosthuizen CB, Lall N, Loots DT (2021) Elucidating the antimycobacterial mechanism of action of ciprofloxacin using metabolomics. Microorganisms 9(6):1158","journal-title":"Microorganisms"},{"issue":"2","key":"557_CR50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/03639045.2013.858740","volume":"41","author":"C Liu","year":"2015","unstructured":"Liu C, Shi J, Dai Q, Yin X, Zhang X, Zheng A (2015) In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration. Drug Dev Ind Pharm 41(2):272\u2013278","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"557_CR51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1099\/jmm.0.000475","volume":"66","author":"S Correia","year":"2017","unstructured":"Correia S, Poeta P, H\u00e9braud M, Capelo JL, Igrejas G (2017) Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol 66(5):551\u2013559","journal-title":"J Med Microbiol"},{"issue":"10","key":"557_CR52","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"KJ Aldred","year":"2014","unstructured":"Aldred KJ, Kerns RJ, Osheroff N (2014) Mechanism of quinolone action and resistance. Biochemistry 53(10):1565\u20131574","journal-title":"Biochemistry"},{"issue":"17","key":"557_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173843","volume":"25","author":"M Yasir","year":"2020","unstructured":"Yasir M, Dutta D, Willcox MD (2020) Activity of antimicrobial peptides and ciprofloxacin against Pseudomonas aeruginosa biofilms. Molecules 25(17):3843","journal-title":"Molecules"},{"issue":"9","key":"557_CR54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","volume":"14","author":"HC Flemming","year":"2016","unstructured":"Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14(9):563\u2013575","journal-title":"Nat Rev Microbiol"},{"key":"557_CR55","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ejmech.2017.06.058","volume":"138","author":"AD Verderosa","year":"2017","unstructured":"Verderosa AD, de la Fuente-N\u00fa\u00f1ez C, Mansour SC, Cao J, Lu TK, Hancock RE, Fairfull-Smith KE (2017) Ciprofloxacin-nitroxide hybrids with potential for biofilm control. Eur J Med Chem 138:590\u2013601","journal-title":"Eur J Med Chem"},{"issue":"23","key":"557_CR56","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.3390\/molecules25235662","volume":"25","author":"NG Bush","year":"2020","unstructured":"Bush NG, Diez-Santos I, Abbott LR, Maxwell A (2020) Quinolones: mechanism, lethality and their contributions to antibiotic resistance. Molecules 25(23):5662","journal-title":"Molecules"},{"key":"557_CR57","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s401663","author":"K Tang","year":"2023","unstructured":"Tang K, Zhao H (2023) Quinolone antibiotics: resistance and therapy. Infect Drug Resist. https:\/\/doi.org\/10.2147\/idr.s401663","journal-title":"Infect Drug Resist"},{"issue":"4","key":"557_CR58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/14740338.2013.796362","volume":"12","author":"R Stahlmann","year":"2013","unstructured":"Stahlmann R, Lode HM (2013) Risks associated with the therapeutic use of fluoroquinolones. Expert Opin Drug Saf 12(4):497\u2013505","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"557_CR59","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2217\/fmb.15.40","volume":"10","author":"V De Lastours","year":"2015","unstructured":"De Lastours V, Fantin B (2015) Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance. Future Microbiol 10(7):1241\u20131255","journal-title":"Future Microbiol"},{"issue":"1","key":"557_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.japh.2018.08.011","volume":"59","author":"DM Molnar","year":"2019","unstructured":"Molnar DM, Kremzner ME (2019) Fluoroquinolones: a hot topic for pharmacists and the Food and Drug Administration\u2019s Division of Drug Information. J Am Pharm Assoc 59(1):13\u201316","journal-title":"J Am Pharm Assoc"},{"key":"557_CR61","unstructured":"Muylaert A & Mainil JG (2013) Fluoroquinolones resistances: the current situation"},{"issue":"5\u20106","key":"557_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-3164.2009.00856.x","volume":"20","author":"JM Blondeau","year":"2009","unstructured":"Blondeau JM (2009) New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Vet Dermatol 20(5\u20106):383\u2013396","journal-title":"Vet Dermatol"},{"key":"557_CR63","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejmech.2014.04.037","volume":"80","author":"ZP Xiao","year":"2014","unstructured":"Xiao ZP, Wang XD, Wang PF, Zhou Y, Zhang JW, Zhang L, Zhou J, Zhou SS, Ouyang H, Lin XY, Mustapa M, Reyinbaike A, Zhu HL (2014) Design, synthesis, and evaluation of novel fluoroquinolone\u2013flavonoid hybrids as potent antibiotics against drug-resistant microorganisms. Eur J Med Chem 80:92\u2013100","journal-title":"Eur J Med Chem"},{"issue":"6","key":"557_CR64","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1089\/mdr.2014.0252","volume":"21","author":"AC Abreu","year":"2015","unstructured":"Abreu AC, Serra SC, Borges A, Saavedra MJ, Mcbain AJ, Salgado AJ, Simoes M (2015) Combinatorial activity of flavonoids with antibiotics against drug-resistant Staphylococcus aureus. Microb Drug Resist 21(6):600\u2013609","journal-title":"Microb Drug Resist"},{"key":"557_CR65","doi-asserted-by":"crossref","unstructured":"Sharma V, Sharma D, Saini M, Jain A, Chaudhary J, Kaur N, Sahoo S, Singh SK, Goyal K, Rekha A, Ali H, Gupta S, Hussain MS & Gupta G (2025) Flavonoids as antimicrobial agents: a comprehensive review of mechanisms and therapeutic potential. Curr Pharmaceutical Biotechnol.","DOI":"10.2174\/0113892010384002250628163849"},{"issue":"15","key":"557_CR66","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.bmc.2014.05.067","volume":"22","author":"S Fardeau","year":"2014","unstructured":"Fardeau S, Dassonville-Klimpt A, Audic N, Sasaki A, Pillon M, Baudrin E, Mulli\u00e9 C, Sonnet P (2014) Synthesis and antibacterial activity of catecholate\u2013ciprofloxacin conjugates. Bioorg Med Chem 22(15):4049\u20134060","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"557_CR67","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00706-018-2215-x","volume":"149","author":"J Fedorowicz","year":"2018","unstructured":"Fedorowicz J, S\u0105czewski J (2018) Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules. Monatsh Chem 149(7):1199\u20131245","journal-title":"Monatsh Chem"},{"key":"557_CR68","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bios.2016.03.003","volume":"81","author":"MK Pawar","year":"2016","unstructured":"Pawar MK, Tayade KC, Sahoo SK, Mahulikar PP, Kuwar AS, Chaudhari BL (2016) Selective ciprofloxacin antibiotic detection by fluorescent siderophore pyoverdin. Biosens Bioelectron 81:274\u2013279","journal-title":"Biosens Bioelectron"},{"issue":"11","key":"557_CR69","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.bmc.2017.02.068","volume":"25","author":"M Shavit","year":"2017","unstructured":"Shavit M, Pokrovskaya V, Belakhov V, Baasov T (2017) Covalently linked kanamycin\u2013ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance. Bioorg Med Chem 25(11):2917\u20132925","journal-title":"Bioorg Med Chem"},{"issue":"24","key":"557_CR70","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1042\/BCJ20220527","volume":"479","author":"DM Foulkes","year":"2022","unstructured":"Foulkes DM, McLean K, Sloniecka M, Rustidge S, Byrne DP, Haneef AS, Winstanley C, Berry N, Fernig DG, Kaye SB (2022) Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity. Biochem J 479(24):2511\u20132527","journal-title":"Biochem J"},{"issue":"Suppl 1","key":"557_CR71","first-page":"A6","volume":"7","author":"S Kaye","year":"2022","unstructured":"Kaye S, McLean K, Foulkes DM, Sloniecka M, Byrne D, Haneef AS, Winstanley C, Berry NG, Fernig DG (2022) P-18 impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity. BMJ Open Ophthalmol 7(Suppl 1):A6\u2013A6","journal-title":"BMJ Open Ophthalmol"},{"key":"557_CR72","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ejmech.2018.07.025","volume":"156","author":"R Wang","year":"2018","unstructured":"Wang R, Yin X, Zhang Y, Yan W (2018) Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids. Eur J Med Chem 156:580\u2013586","journal-title":"Eur J Med Chem"},{"issue":"10","key":"557_CR73","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/jhet.3279","volume":"55","author":"H Guo","year":"2018","unstructured":"Guo H (2018) Design, synthesis, and antibacterial evaluation of propylene-tethered 8-methoxyl ciprofloxacin-isatin hybrids. J Heterocycl Chem 55(10):2434\u20132440","journal-title":"J Heterocycl Chem"},{"key":"557_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103162","volume":"91","author":"F Gao","year":"2019","unstructured":"Gao F, Ye L, Kong F, Huang G, Xiao J (2019) Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1, 2, 3-triazole-isatin hybrids. Bioorg Chem 91:103162","journal-title":"Bioorg Chem"},{"key":"557_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.135135","volume":"1282","author":"EO Osman","year":"2023","unstructured":"Osman EO, Attia H, Samir R, Mahmoud Z (2023) Design, synthesis, and antibacterial activity of a new series of ciprofloxacin-thiadiazole hybrid. J Mol Struct 1282:135135","journal-title":"J Mol Struct"},{"issue":"10","key":"557_CR76","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00706-019-02478-4","volume":"150","author":"HH Mohammed","year":"2019","unstructured":"Mohammed HH, Abbas SH, Abdelhafez ESM, Berger JM, Mitarai S, Arai M, Abuo-Rahma GEDA (2019) Synthesis, molecular docking, antimicrobial evaluation, and DNA cleavage assay of new thiadiazole\/oxadiazole ciprofloxacin derivatives. Monatsh Chem 150(10):1809\u20131824","journal-title":"Monatsh Chem"},{"key":"557_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104383","volume":"105","author":"H Ahadi","year":"2020","unstructured":"Ahadi H, Shokrzadeh M, Hosseini-Khah Z, Ghasemian M, Emadi E, Zargari M, Razzaghi-Asl M, Emami S (2020) Synthesis and biological assessment of ciprofloxacin-derived 1, 3, 4-thiadiazoles as anticancer agents. Bioorg Chem 105:104383","journal-title":"Bioorg Chem"},{"issue":"1","key":"557_CR78","first-page":"12","volume":"6","author":"EMN Abdelhafez","year":"2023","unstructured":"Abdelhafez EMN, Elgedamy A, Shoman M (2023) Antimicrobial activity of new amide\/thioamides derivatives of ciprofloxacin. J Adv Biomed Pharmaceutic Sci 6(1):12\u201315","journal-title":"J Adv Biomed Pharmaceutic Sci"},{"key":"557_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114021","volume":"228","author":"NM Ibrahim","year":"2022","unstructured":"Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH (2022) Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: potency and side effects. Eur J Med Chem 228:114021","journal-title":"Eur J Med Chem"},{"issue":"21","key":"557_CR80","doi-asserted-by":"publisher","first-page":"19077","DOI":"10.1021\/acs.jmedchem.4c01555","volume":"67","author":"B Marinacci","year":"2024","unstructured":"Marinacci B, D\u2019Agostino I, Angeli A, Carradori S, Melfi F, Grande R, Corsiani M, Ferraroni M, Agamennone M, Tondo AR, Zara S, Puca V, Pellegrini B, Vagaggini C, Dreassi E, Patrauchan MA, Capasso C, Nicolotti O, Carta F, Supuran CT (2024) Inhibition of Pseudomonas aeruginosa carbonic anhydrases, exploring ciprofloxacin functionalization toward new antibacterial agents: an in-depth multidisciplinary study. J Med Chem 67(21):19077\u201319102","journal-title":"J Med Chem"},{"issue":"12","key":"557_CR81","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1016\/j.bmc.2012.04.034","volume":"20","author":"C Ji","year":"2012","unstructured":"Ji C, Miller MJ (2012) Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers. Bioorg Med Chem 20(12):3828\u20133836","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"557_CR82","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1021\/acsmedchemlett.5b00146","volume":"6","author":"C Ji","year":"2015","unstructured":"Ji C, Miller PA, Miller MJ (2015) Syntheses and antibacterial activity of N-acylated ciprofloxacin derivatives based on the trimethyl lock. ACS Med Chem Lett 6(6):707\u2013710","journal-title":"ACS Med Chem Lett"},{"key":"557_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fmats.2023.1255955","volume":"10","author":"GM Alasadi","year":"2023","unstructured":"Alasadi GM, Al-Obaidi Z (2023) Synthesis of novel acylated and esterified ciprofloxacin derivatives as efficient anticancer and antimicrobial agents. Front Mater 10:1255955","journal-title":"Front Mater"},{"issue":"21","key":"557_CR84","doi-asserted-by":"publisher","first-page":"18663","DOI":"10.1021\/acsomega.3c00554","volume":"8","author":"M Struga","year":"2023","unstructured":"Struga M, Roszkowski P, Bielenica A, Otto-Slusarczyk D, St\u0119pie\u0144 K, Stefanska J, Zabost A, Augustynowicz-Kopec E, Kolinski M, Kmiecik S, Myslovska A, Wrzosek M (2023) N-Acylated ciprofloxacin derivatives: synthesis and in vitro biological evaluation as antibacterial and anticancer agents. ACS Omega 8(21):18663\u201318684","journal-title":"ACS Omega"},{"issue":"2","key":"557_CR85","first-page":"308","volume":"4","author":"K Gupta","year":"2011","unstructured":"Gupta K, Pandeya SN, Pathak AK, Gupta A (2011) Synthesis and antibacterial activity of ciprofloxacin derivatives. Res J Pharm Technol 4(2):308\u2013314","journal-title":"Res J Pharm Technol"},{"issue":"5","key":"557_CR86","first-page":"390","volume":"3","author":"YM Thakre","year":"2011","unstructured":"Thakre YM, Choudhary MD (2011) Synthesis, characterization and evaluation of derivative of ciprofloxacin (1-cyclopropyl-6-fluoro-4-oxo-7-[4-(phenyl carbonyl) piperazin-1-yl]-1, 4-dihydroquinoline-3-carboxylic acid) and their complexes. J Chem Pharm Res 3(5):390\u2013398","journal-title":"J Chem Pharm Res"},{"issue":"1","key":"557_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/scipharm90010002","volume":"90","author":"H Hryhoriv","year":"2021","unstructured":"Hryhoriv H, Mariutsa I, Kovalenko SM, Georgiyants V, Perekhoda L, Filimonova N, Geyderikh O, Sidorenko L (2021) The search for new antibacterial agents among 1, 2, 3-triazole functionalized ciprofloxacin and norfloxacin hybrids: synthesis, docking studies, and biological activity evaluation. Sci Pharm 90(1):2","journal-title":"Sci Pharm"},{"key":"557_CR88","doi-asserted-by":"crossref","unstructured":"Al-Taweel S, Al-Saraireh Y, Al-Trawneh S, Alshahateet S, Al-Tarawneh R, Ayed N, Alkhojah M, AL-Khaboori W, Zereini W & Al-Qaralleh O (2023) Synthesis and biological evaluation of ciprofloxacin\u20131, 2, 3-triazole hybrids as antitumor, antibacterial, and antioxidant agents. Heliyon 9(12): e22592","DOI":"10.1016\/j.heliyon.2023.e22592"},{"issue":"24","key":"557_CR89","doi-asserted-by":"publisher","first-page":"17051","DOI":"10.1039\/D4RA01332H","volume":"14","author":"UK Patel","year":"2024","unstructured":"Patel UK, Tiwari P, Tilak R, Joshi G, Kumar R, Agarwal A (2024) Synthesis of ciprofloxacin-linked 1, 2, 3-triazole conjugates as potent antibacterial agents using click chemistry: exploring their function as DNA gyrase inhibitors via in silico-and in vitro-based studies. RSC Adv 14(24):17051\u201317070","journal-title":"RSC Adv"},{"key":"557_CR90","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2013.07.032","volume":"68","author":"S Emami","year":"2013","unstructured":"Emami S, Ghafouri E, Faramarzi MA, Samadi N, Irannejad H, Foroumadi A (2013) Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study. Eur J Med Chem 68:185\u2013191","journal-title":"Eur J Med Chem"},{"issue":"5","key":"557_CR91","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ph14050399","volume":"14","author":"LH Al-Wahaibi","year":"2021","unstructured":"Al-Wahaibi LH, Amer AA, Marzouk AA, Gomaa HA, Youssif BG, Abdelhamid AA (2021) Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors. Pharmaceuticals Basel 14(5):399","journal-title":"Pharmaceuticals Basel"},{"key":"557_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104629","volume":"107","author":"IM Abdel-Rahman","year":"2021","unstructured":"Abdel-Rahman IM, Mustafa M, Mohamed SA, Yahia R, Abdel-Aziz M, Abuo-Rahma GEDA, Hayallah AM (2021) Novel Mannich bases of ciprofloxacin with improved physicochemical properties, antibacterial, anticancer activities and caspase-3 mediated apoptosis. Bioorg Chem 107:104629","journal-title":"Bioorg Chem"},{"key":"557_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28573","author":"AM Abdula","year":"2024","unstructured":"Abdula AM, Qarah AF, Alatawi K, Qurban J, Abualnaja MM, Katuah HA, El-Metwaly NM (2024) Design, synthesis, and molecular docking of new phenothiazine incorporated N-Mannich bases as promising antimicrobial agents. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28573","journal-title":"Heliyon"},{"issue":"3","key":"557_CR94","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jscs.2011.10.022","volume":"17","author":"CR Prakash","year":"2013","unstructured":"Prakash CR, Raja S (2013) Synthesis, characterization and in vitro antimicrobial activity of some novel 5-substituted Schiff and Mannich base of isatin derivatives. J Saudi Chem Soc 17(3):337\u2013344","journal-title":"J Saudi Chem Soc"},{"issue":"2","key":"557_CR95","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3329\/jsr.v13i2.49508","volume":"13","author":"MG Rabbani","year":"2021","unstructured":"Rabbani MG, Islam MR (2021) Synthesis and characterization of some Mannich base analogues of ciprofloxacin: antibacterial, antifungal, and cytotoxic activities. J Sci Res 13(2):545\u2013559","journal-title":"J Sci Res"},{"key":"557_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104658","volume":"108","author":"A Alsughayer","year":"2021","unstructured":"Alsughayer A, Elassar AZA, Hasan AA, Al Sagheer F (2021) Antibiotic resistance and drug modification: synthesis, characterization and bioactivity of newly modified potent ciprofloxacin derivatives. Bioorg Chem 108:104658","journal-title":"Bioorg Chem"},{"issue":"3","key":"557_CR97","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1570180817999201016154034","volume":"18","author":"YU Cebeci","year":"2021","unstructured":"Cebeci YU, Ceylan S, Demirbas N, Karao\u011flu \u015eA (2021) Microwave-assisted synthesis of novel Mannich base and conazole derivatives containing biologically active pharmacological groups. Lett Drug Des Discov 18(3):269\u2013283","journal-title":"Lett Drug Des Discov"},{"key":"557_CR98","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejmech.2015.04.058","volume":"97","author":"T Plech","year":"2015","unstructured":"Plech T, Kapro\u0144 B, Paneth A, Kosikowska U, Malm A, Strzelczyk A, St\u0105czek P, \u015awi\u0105tek L, Rajtar B, Polz-Dacewicz M (2015) Search for factors affecting antibacterial activity and toxicity of 1, 2, 4-triazole-ciprofloxacin hybrids. Eur J Med Chem 97:94\u2013103","journal-title":"Eur J Med Chem"},{"issue":"1","key":"557_CR99","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1515\/hc-2020-0126","volume":"27","author":"YU Cebeci","year":"2021","unstructured":"Cebeci YU, Karao\u011flu \u015eA (2021) Design and microwave-assisted synthesis of a novel Mannich base and conazole derivatives and their biological assessment. Heterocycl Commun 27(1):100\u2013111","journal-title":"Heterocycl Commun"},{"key":"557_CR100","doi-asserted-by":"crossref","unstructured":"Sahoo CR, Rout M, Paidesetty SK, Dehury B, Bhattacharya D & Pati S (2025) Molecular simulation of newly designed Mannich-based ciprofloxacin derivative as the promising scaffold for E. coli dihydropteroate synthase and DNA gyrase inhibitor. J Biomol Struct Dyn 43(16):9487\u20139501","DOI":"10.1080\/07391102.2025.2459263"},{"issue":"4","key":"557_CR101","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.bmcl.2012.12.045","volume":"23","author":"X Li","year":"2013","unstructured":"Li X, Zhang YK, Plattner JJ, Mao W, Alley MRK, Xia Y, Hernandez V, Zhou Y, Ding CZ, Li J, Shao Z, Zhang H, Xu M (2013) Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone. Bioorg Med Chem Lett 23(4):963\u2013966","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"557_CR102","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3184\/030823405774308943","volume":"2005","author":"MM Heravi","year":"2005","unstructured":"Heravi MM, Jaddi ZS, Oskooie HA, Khaleghi S, Ghassemzadeh M (2005) Regioselective synthesis of quinolone antibacterials via borate complex of quinolone carboxylic acid. J Chem Res 2005(9):578\u2013579","journal-title":"J Chem Res"},{"issue":"2","key":"557_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47020110","volume":"47","author":"LA Veyna-Hurtado","year":"2025","unstructured":"Veyna-Hurtado LA, Hern\u00e1ndez-L\u00f3pez H, Reyes-Escobedo FDR, de Loera D, Garc\u00eda-Cruz S, Troncoso-V\u00e1zquez L, Galv\u00e1n-Valencia M, Casta\u00f1eda-Delgado JE, Cervantes-Villagrana AR (2025) The derivative Difluoroboranyl-Fluoroquinolone \u201c7a\u201d generates effective inhibition against the S. aureus strain in a murine model of acute pneumonia. Curr Issues Mol Biol 47(2):110","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"557_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000180","volume":"354","author":"HA Aziz","year":"2021","unstructured":"Aziz HA, Moustafa GA, Abuo\u2010Rahma GEDA, Rabea SM, Hauk G, Krishna VS, Sriram D, Berger JM, Abbas SH (2021) Synthesis and antimicrobial evaluation of new nitric oxide\u2010donating fluoroquinolone\/oxime hybrids. Arch Pharm 354(1):2000180","journal-title":"Arch Pharm"},{"key":"557_CR105","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ejmech.2014.09.029","volume":"86","author":"H Liu","year":"2014","unstructured":"Liu H, Huang J, Wang J, Wang M, Liu M, Wang B, Guo H, Lu Y (2014) Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl] fluoroquinolone derivatives containing an oxime functional moiety. Eur J Med Chem 86:628\u2013638","journal-title":"Eur J Med Chem"},{"issue":"13","key":"557_CR106","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1016\/j.bmcl.2006.03.103","volume":"16","author":"A Foroumadi","year":"2006","unstructured":"Foroumadi A, Ghodsi S, Emami S, Najjari S, Samadi N, Faramarzi MA, Beikmohammadi L, Shirazi FH, Shafiee A (2006) Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl) piperazine moiety. Bioorg Med Chem Lett 16(13):3499\u20133503","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"557_CR107","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.bmcl.2016.03.050","volume":"26","author":"J Huang","year":"2016","unstructured":"Huang J, Wang M, Wang B, Wu Z, Liu M, Feng L, Zhang J, Li X, Yang Y, Lu Y (2016) Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3, 5-difluoropyridin-2-yl) fluoroquinolone derivatives containing an oxime functional moiety. Bioorg Med Chem Lett 26(9):2262\u20132267","journal-title":"Bioorg Med Chem Lett"},{"key":"557_CR108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejmech.2015.09.030","volume":"104","author":"T Zhang","year":"2015","unstructured":"Zhang T, Shen W, Liu M, Zhang R, Wang M, Li L, Wang B, Guo H, Lu Y (2015) Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo) methylpyrrolidine moiety. Eur J Med Chem 104:73\u201385","journal-title":"Eur J Med Chem"},{"issue":"11","key":"557_CR109","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1016\/j.bmcl.2011.04.002","volume":"21","author":"Y Chai","year":"2011","unstructured":"Chai Y, Wang J, Liu M, Yi H, Sun L, You X, Guo H (2011) Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl) fluoroquinolone derivatives. Bioorg Med Chem Lett 21(11):3377\u20133380","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"557_CR110","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.ejmech.2011.03.026","volume":"46","author":"JX Wang","year":"2011","unstructured":"Wang JX, Zhang YB, Liu ML, Wang B, Chai Y, Li SJ, Guo HY (2011) Synthesis and in vitro antibacterial activity of 7-(3-Alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives. Eur J Med Chem 46(6):2421\u20132426","journal-title":"Eur J Med Chem"},{"issue":"10","key":"557_CR111","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1016\/j.ejmech.2009.04.041","volume":"44","author":"Y Chai","year":"2009","unstructured":"Chai Y, Wan ZL, Wang B, Guo HY, Liu ML (2009) Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl) fluoroquinolone derivatives. Eur J Med Chem 44(10):4063\u20134069","journal-title":"Eur J Med Chem"},{"issue":"2","key":"557_CR112","first-page":"554","volume":"16","author":"E Valadbeigi","year":"2017","unstructured":"Valadbeigi E, Ghodsi S (2017) Synthesis and study of some new quinolone derivatives containing a 3-acetyl coumarin for their antibacterial and antifungal activities. Iran J Pharmaceutic Res 16(2):554","journal-title":"Iran J Pharmaceutic Res"},{"issue":"2","key":"557_CR113","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF03245841","volume":"6","author":"A Shafiee","year":"2009","unstructured":"Shafiee A, Emami S, Ghodsi S, Najjari S, Sorkhi M, Samadi N, Faramarzi MA, Foroumadi A (2009) Synthesis and antibacterial activity of N-[2-(2-naphthyl) ethyl] piperazinyl quinolones. J Iran Chem Soc 6(2):325\u2013333","journal-title":"J Iran Chem Soc"},{"key":"557_CR114","unstructured":"Shafiei A, Hadad ZM, Mohammad HN, Khalafi J, Emami S, Moshefi M, Sorkhi M & Foroumadi A (2008) Synthesis and in-vitro antibacterial activity of N-piperazinyl quinolone derivatives with 5-chloro-2-thienyl group"},{"issue":"6","key":"557_CR115","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.bmcl.2013.01.048","volume":"23","author":"K Lv","year":"2013","unstructured":"Lv K, Wu J, Wang J, Liu M, Wei Z, Cao J, Sun Y, Guo H (2013) Synthesis and in vitro antibacterial activity of quinolone\/naphthyridone derivatives containing 3-alkoxyimino-4-(methyl) aminopiperidine scaffolds. Bioorg Med Chem Lett 23(6):1754\u20131759","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"557_CR116","first-page":"860","volume":"45","author":"ZL Wan","year":"2010","unstructured":"Wan ZL, Chai Y, Liu ML, Guo HY, Sun LY (2010) Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-methyl-3-methylaminopiperidin-1-yl) quinolones. Yao Xue Xue Bao 45(7):860\u2013868","journal-title":"Yao Xue Xue Bao"},{"issue":"8","key":"557_CR117","first-page":"819","volume":"43","author":"XY Wang","year":"2008","unstructured":"Wang XY, Guo Q, Wang YC, Liu BQ, Liu ML, Sun LY, Guo HY (2008) Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1-piperidyl)-quinolones. Yao Xue Xue Bao 43(8):819\u2013827","journal-title":"Yao Xue Xue Bao"},{"issue":"11","key":"557_CR118","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1016\/j.ejmech.2011.09.011","volume":"46","author":"AM Alaa","year":"2011","unstructured":"Alaa AM, Asiri YA, Al-Agamy MH (2011) Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study. Eur J Med Chem 46(11):5487\u20135497","journal-title":"Eur J Med Chem"},{"issue":"2","key":"557_CR119","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00044-012-0074-2","volume":"22","author":"KM Agrawal","year":"2013","unstructured":"Agrawal KM, Talele GS (2013) Synthesis and antibacterial, antimycobacterial and docking studies of novel N-piperazinyl fluoroquinolones. Med Chem Res 22(2):818\u2013831","journal-title":"Med Chem Res"},{"key":"557_CR120","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","volume":"167","author":"LL Wang","year":"2019","unstructured":"Wang LL, Battini N, Bheemanaboina RRY, Zhang SL, Zhou CH (2019) Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation. Eur J Med Chem 167:105\u2013123","journal-title":"Eur J Med Chem"},{"issue":"19","key":"557_CR121","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1016\/j.bmcl.2011.07.060","volume":"21","author":"ST Nguyen","year":"2011","unstructured":"Nguyen ST, Ding X, Butler MM, Tashjian TF, Peet NP, Bowlin TL (2011) Preparation and antibacterial evaluation of decarboxylated fluoroquinolones. Bioorg Med Chem Lett 21(19):5961\u20135963","journal-title":"Bioorg Med Chem Lett"},{"issue":"15","key":"557_CR122","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1016\/j.bmcl.2011.05.112","volume":"21","author":"KR Marks","year":"2011","unstructured":"Marks KR, Malik M, Mustaev A, Hiasa H, Drlica K, Kerns RJ (2011) Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones. Bioorg Med Chem Lett 21(15):4585\u20134588","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"557_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24020954","volume":"24","author":"A Lukin","year":"2023","unstructured":"Lukin A, Komarova K, Vinogradova L, Rogacheva E, Kraeva L, Krasavin M (2023) Synthesis and antibacterial evaluation of ciprofloxacin congeners with spirocyclic amine periphery. Int J Mol Sci 24(2):954","journal-title":"Int J Mol Sci"},{"issue":"15","key":"557_CR124","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.3390\/molecules27154864","volume":"27","author":"A Lukin","year":"2022","unstructured":"Lukin A, Chudinov M, Vedekhina T, Rogacheva E, Kraeva L, Bakulina O, Krasavin M (2022) Exploration of spirocyclic derivatives of ciprofloxacin as antibacterial agents. Molecules 27(15):4864","journal-title":"Molecules"},{"issue":"4","key":"557_CR125","doi-asserted-by":"publisher","first-page":"6","DOI":"10.22159\/ijap.2018v10i4.25315","volume":"10","author":"M Vidyavathi","year":"2018","unstructured":"Vidyavathi M, Srividya G (2018) A review on ciprofloxacin: dosage form perspective. Int J Appl Pharm 10(4):6\u201310","journal-title":"Int J Appl Pharm"},{"key":"557_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01441","volume":"9","author":"PV Baptista","year":"2018","unstructured":"Baptista PV, McCusker MP, Carvalho A, Ferreira DA, Mohan NM, Martins M, Fernandes AR (2018) Nano-strategies to fight multidrug resistant bacteria\u2014\u201cA Battle of the Titans.\u201d Front Microbiol 9:1441","journal-title":"Front Microbiol"},{"issue":"10","key":"557_CR127","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1016\/j.xphs.2016.06.022","volume":"105","author":"N Thomas","year":"2016","unstructured":"Thomas N, Thorn C, Richter K, Thierry B, Prestidge C (2016) Efficacy of poly-lactic-co-glycolic acid micro-and nanoparticles of ciprofloxacin against bacterial biofilms. J Pharm Sci 105(10):3115\u20133122","journal-title":"J Pharm Sci"},{"key":"557_CR128","doi-asserted-by":"crossref","unstructured":"Munir MU, Ahmed A, Usman M & Salman S (2020) Recent advances in nanotechnology-aided materials in combating microbial resistance and functioning as antibiotics substitutes. Int J Nanomed 15:7329\u20137358","DOI":"10.2147\/IJN.S265934"},{"key":"557_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02522","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang L, Di Luca M, Tkhilaishvili T, Trampuz A, Gonzalez Moreno M (2019) Synergistic activity of fosfomycin, ciprofloxacin, and gentamicin against Escherichia coli and Pseudomonas aeruginosa biofilms. Front Microbiol 10:2522","journal-title":"Front Microbiol"},{"issue":"5","key":"557_CR130","first-page":"1041","volume":"26","author":"F Yasmin","year":"2013","unstructured":"Yasmin F, Akhtar N, Hameed A (2013) In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa. Pak J Pharm Sci 26(5):1041\u20131045","journal-title":"Pak J Pharm Sci"},{"issue":"8","key":"557_CR131","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41429-021-00427-0","volume":"74","author":"H Ren","year":"2021","unstructured":"Ren H, Zhang J, Zhou J, Xu C, Fan Z, Pan X, Li S, Liang Y, Chen S, Xu J, Wang P, Zhang Y, Zhu G, Liu H, Jin Y, Bai F, Cheng Z, Pletzer D, Wu W (2021) Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae. J Antibiot 74(8):528\u2013537","journal-title":"J Antibiot"},{"issue":"9","key":"557_CR132","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.5958\/0974-360X.2020.00779.9","volume":"13","author":"MK Abbas","year":"2020","unstructured":"Abbas MK, Kadhum DA, Shabeeb AK, Mohammed SA (2020) Combination effect of ciprofloxacin and streptomycin with cefotaxime against multi-drug resistant Pseudomonas aeruginosa from different clinical samples. Res J Pharm Technol 13(9):4403\u20134408","journal-title":"Res J Pharm Technol"},{"key":"557_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111321","volume":"199","author":"T Khare","year":"2021","unstructured":"Khare T, Mahalunkar S, Shriram V, Gosavi S, Kumar V (2021) Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli. Environ Res 199:111321","journal-title":"Environ Res"},{"key":"557_CR134","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jphotobiol.2016.02.036","volume":"158","author":"MR Ronqui","year":"2016","unstructured":"Ronqui MR, de Aguiar TMSF, De Freitas LM, Miranda ET, Fontana CR (2016) Synergistic antimicrobial effect of photodynamic therapy and ciprofloxacin. J Photochem Photobiol B 158:122\u2013129","journal-title":"J Photochem Photobiol B"},{"issue":"1","key":"557_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14139-5","volume":"11","author":"LW Roberts","year":"2020","unstructured":"Roberts LW, Harris PN, Forde BM, Ben Zakour NL, Catchpoole E, Stanton-Cook M, Phan MD, Sidjabat HE, Bergh H, Heney C, Gawthorne JA, Lipman J, Allworth A, Chan KG, Chong TM, Yin WF, Schembri MA, Paterson DL, Beatson SA (2020) Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei. Nat Commun 11(1):466","journal-title":"Nat Commun"},{"issue":"2","key":"557_CR136","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.eimc.2016.05.009","volume":"35","author":"JL G\u00f3mez-Garc\u00e9s","year":"2016","unstructured":"G\u00f3mez-Garc\u00e9s JL, Gil-Romero Y, Vazquez O, Merino F (2016) Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae. Enferm Infecc Microbiol Clin 35(2):135\u2013136","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"557_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01556","volume":"10","author":"R Domalaon","year":"2019","unstructured":"Domalaon R, Ammeter D, Brizuela M, Gorityala BK, Zhanel GG, Schweizer F (2019) Repurposed antimicrobial combination therapy: tobramycin-ciprofloxacin hybrid augments activity of the anticancer drug mitomycin C against multidrug-resistant Gram-negative bacteria. Front Microbiol 10:1556","journal-title":"Front Microbiol"},{"issue":"9","key":"557_CR138","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1021\/acs.bioconjchem.7b00424","volume":"28","author":"M Schmidt","year":"2017","unstructured":"Schmidt M, Bast LK, Lanfer F, Richter L, Hennes E, Seymen R, Krumm C, Tiller JC (2017) Poly (2-oxazoline)\u2013antibiotic conjugates with penicillins. Bioconjug Chem 28(9):2440\u20132451","journal-title":"Bioconjug Chem"},{"issue":"7","key":"557_CR139","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10118-021-2547-6","volume":"39","author":"S Dong","year":"2021","unstructured":"Dong S, Ma S, Liu ZL, Ma LL, Zhang Y, Tang ZH et\u00a0al (2021) Functional amphiphilic poly (2-oxazoline) block copolymers as drug carriers: the relationship between structure and drug loading capacity. Chinese J Polymer Sci 39(7):865\u2013873","journal-title":"Chinese J Polymer Sci"},{"key":"557_CR140","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15379\/2410-3802.2017.03.02","volume":"3","author":"P Shah","year":"2017","unstructured":"Shah P, Chen CS (2017) Combinational synergy of antibiotics and antimicrobial peptides. J Transl Proteomics Res 3:6\u201311","journal-title":"J Transl Proteomics Res"},{"issue":"11","key":"557_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204081","volume":"13","author":"T Ramirez-Mora","year":"2018","unstructured":"Ramirez-Mora T, Retana-Lobo C, Valle-Bourrouet G (2018) Biochemical characterization of extracellular polymeric substances from endodontic biofilms. PLoS ONE 13(11):e0204081","journal-title":"PLoS ONE"},{"key":"557_CR142","doi-asserted-by":"crossref","unstructured":"Yang R, Ma X, Peng F, Wen J, Allahou LW, Williams GR et al (2025) Advances in antimicrobial peptides: from mechanistic insights to chemical modifications. Biotechnol Adv 81:108570","DOI":"10.1016\/j.biotechadv.2025.108570"},{"issue":"9","key":"557_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091223","volume":"21","author":"H Rudilla","year":"2016","unstructured":"Rudilla H, Fust\u00e9 E, Cajal Y, Rabanal F, Vinuesa T, Vi\u00f1as M (2016) Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems. Molecules 21(9):1223","journal-title":"Molecules"},{"key":"557_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1119574","volume":"14","author":"DI Duarte-Mata","year":"2023","unstructured":"Duarte-Mata DI, Salinas-Carmona MC (2023) Antimicrobial peptides immune modulation role in intracellular bacterial infection. Front Immunol 14:1119574","journal-title":"Front Immunol"},{"issue":"2","key":"557_CR145","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/acsinfecdis.4c00702","volume":"11","author":"RM Gon\u00e7alves","year":"2025","unstructured":"Gon\u00e7alves RM, Monges BED, Oshiro KGN, C\u00e2ndido EDS, Pimentel JPF, Franco OL, Cardoso MH (2025) Advantages and challenges of using antimicrobial peptides in synergism with antibiotics for treating multidrug-resistant bacteria. ACS Infect Dis 11(2):323\u2013334","journal-title":"ACS Infect Dis"},{"issue":"10","key":"557_CR146","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/antibiotics10101159","volume":"10","author":"M Yasir","year":"2021","unstructured":"Yasir M, Dutta D, Willcox MD (2021) Enhancement of antibiofilm activity of Ciprofloxacin against Staphylococcus aureus by administration of antimicrobial peptides. Antibiotics 10(10):1159","journal-title":"Antibiotics"},{"issue":"6","key":"557_CR147","first-page":"1095","volume":"44","author":"J Mwangi","year":"2023","unstructured":"Mwangi J, Kamau PM, Thuku RC, Lai R (2023) Design methods for antimicrobial peptides with improved performance. Zool Res 44(6):1095","journal-title":"Zool Res"},{"issue":"1","key":"557_CR148","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"CD Fjell","year":"2012","unstructured":"Fjell CD, Hiss JA, Hancock RE, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11(1):37\u201351","journal-title":"Nat Rev Drug Discov"},{"issue":"48","key":"557_CR149","doi-asserted-by":"publisher","first-page":"22377","DOI":"10.1039\/D3NJ04003H","volume":"47","author":"JB Zhen","year":"2023","unstructured":"Zhen JB, Yi JJ, Liu BX, Liu YJ, Bu XY, Wu XJ, Tang D (2023) Ciprofloxacin peptide-based nanoparticles confer antimicrobial efficacy against multidrug-resistant bacteria. New J Chem 47(48):22377\u201322387","journal-title":"New J Chem"},{"issue":"36","key":"557_CR150","doi-asserted-by":"publisher","first-page":"15722","DOI":"10.1039\/D4NJ01445F","volume":"48","author":"JR Connolly","year":"2024","unstructured":"Connolly JR, Fitzgerald-Hughes D, Maresca M, Muldoon J, Devocelle M (2024) Ciprofloxacin as a tryptophan mimic within an antimicrobial peptide. New J Chem 48(36):15722\u201315725","journal-title":"New J Chem"},{"key":"557_CR151","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c02285","author":"B Almarwani","year":"2025","unstructured":"Almarwani B, Phambu N, Sunda-Meya A (2025) Synergistic Ciprofloxacin-RWn peptide therapy overcomes drug resistance in Gram-negative bacteria. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.5c02285","journal-title":"ACS Omega"},{"key":"557_CR152","doi-asserted-by":"crossref","unstructured":"Monteiro-Alfredo T, de O Gutierrez C, Almeida CV, da Silva VC, Gomes P, de Oliveira CF, Madalozzo ES, Crusca E, Orozco RMQ, Lima L, Cardoso MH, Franco OL & Macedo MLR (2025) Design and evaluation of the antibacterial peptide FK18: a therapeutic approach for mastitis in dairy animals. Probiotics Antimicrobial Proteins 1\u201316","DOI":"10.1007\/s12602-025-10794-x"},{"issue":"6","key":"557_CR153","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2174\/1389450116666151001103948","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Venter H, Ma S (2016) Efflux pump inhibitors: a novel approach to combat efflux-mediated drug resistance in bacteria. Curr Drug Targets 17(6):702\u2013719","journal-title":"Curr Drug Targets"},{"key":"557_CR154","doi-asserted-by":"crossref","unstructured":"Sau S, Kaur B & Sharma S (2025) Potentiation of ciprofloxacin activity by chalcones by modulating efflux pump and biofilm regulatory gene in staphylococcus aureus. Int J Appl Pharmaceutics","DOI":"10.22159\/ijap.2025v17i4.54253"},{"issue":"4","key":"557_CR155","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acsinfecdis.2c00549","volume":"9","author":"S Dhiman","year":"2023","unstructured":"Dhiman S, Ramirez D, Li Y, Kumar A, Arthur G, Schweizer F (2023) Chimeric tobramycin-based adjuvant TOB-TOB-CIP potentiates fluoroquinolone and \u03b2-lactam antibiotics against multidrug-resistant Pseudomonas aeruginosa. ACS Infect Dis 9(4):864\u2013885","journal-title":"ACS Infect Dis"},{"issue":"4","key":"557_CR156","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1128\/AAC.01231-08","volume":"53","author":"MN Al-Hasan","year":"2009","unstructured":"Al-Hasan MN, Wilson JW, Lahr BD, Thomsen KM, Eckel-Passow JE, Vetter EA, Tleyjeh IM, Baddour LM (2009) \u03b2-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother 53(4):1386\u20131394","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"557_CR157","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/jac\/dkp067","volume":"63","author":"B Jeon","year":"2009","unstructured":"Jeon B, Zhang Q (2009) Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter. J Antimicrob Chemother 63(5):946\u2013948","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"557_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24167-5","volume":"15","author":"M Momin-Reza","year":"2025","unstructured":"Momin-Reza M, Rafi RH, Mia R, Tawfiq MJ, Khan MRI, Faruqe MO, Ehaimir SY, Al-Bari MAA (2025) Evaluating the ciprofloxacin potentiation efficacy of repurposed drug flupentixol through efflux pump inhibition of pathogenic bacteria. Sci Rep 15(1):40239","journal-title":"Sci Rep"},{"issue":"8","key":"557_CR159","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.14202\/vetworld.2022.2039-2045","volume":"15","author":"W Pelyuntha","year":"2022","unstructured":"Pelyuntha W, Sanguankiat A, Kovitvadhi A, Vongkamjan K (2022) Broad lytic spectrum of novel Salmonella phages on ciprofloxacin-resistant Salmonella contaminated in the broiler production chain. Vet World 15(8):2039","journal-title":"Vet World"},{"issue":"1","key":"557_CR160","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","volume":"19","author":"Z Chegini","year":"2020","unstructured":"Chegini Z, Khoshbayan A, Taati Moghadam M, Farahani I, Jazireian P, Shariati A (2020) Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann Clin Microbiol Antimicrob 19(1):45","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"557_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13090870","volume":"13","author":"L Cui","year":"2024","unstructured":"Cui L, Watanabe S, Miyanaga K, Kiga K, Sasahara T, Aiba Y, Tan X-E, Veeranarayanan S, Thitiananpakorn K, Nguyen HM, Wannigama DL (2024) A comprehensive review on phage therapy and phage-based drug development. Antibiotics Basel 13(9):870","journal-title":"Antibiotics Basel"},{"key":"557_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00775","volume":"9","author":"M Rossitto","year":"2018","unstructured":"Rossitto M, Fiscarelli EV, Rosati P (2018) Challenges and promises for planning future clinical research into bacteriophage therapy against Pseudomonas aeruginosa in cystic fibrosis. An argumentative review. Front Microbiol 9:775","journal-title":"Front Microbiol"},{"issue":"2","key":"557_CR163","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1128\/AAC.01774-15","volume":"60","author":"JY Nale","year":"2016","unstructured":"Nale JY, Spencer J, Hargreaves KR, Buckley AM, Trzepi\u0144ski P, Douce GR, Clokie MR (2016) Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo. Antimicrob Agents Chemother 60(2):968\u2013981","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"557_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02576-4","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H, Yang Y, Xu Y, Chen Y, Zhang W, Liu T, Chen G, Wang K (2024) Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. J Nanobiotechnology 22(1):365","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"557_CR165","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/22221751.2019.1626197","volume":"8","author":"K Chen","year":"2019","unstructured":"Chen K, Dong N, Chan EWC, Chen S (2019) Transmission of ciprofloxacin resistance in Salmonella mediated by a novel type of conjugative helper plasmids. Emerg Microbes Infect 8(1):857\u2013865","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"557_CR166","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02874-22","volume":"10","author":"AA Ferran","year":"2022","unstructured":"Ferran AA, Lacroix MZ, Gourbeyre O, Huesca A, Gaborieau B, Debarbieux L, Bousquet-M\u00e9lou A (2022) The selection of antibiotic-and bacteriophage-resistant Pseudomonas aeruginosa is prevented by their combination. Microbiol Spectr 10(5):e02874-22","journal-title":"Microbiol Spectr"},{"issue":"3","key":"557_CR167","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/jam.15647","volume":"133","author":"DJ Holger","year":"2022","unstructured":"Holger DJ, Lev KL, Kebriaei R, Morrisette T, Shah R, Alexander J, Lehman SM, Rybak MJ (2022) Bacteriophage\u2010antibiotic combination therapy for multidrug\u2010resistant Pseudomonas aeruginosa: in vitro synergy testing. J Appl Microbiol 133(3):1636\u20131649","journal-title":"J Appl Microbiol"},{"key":"557_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123853","volume":"652","author":"Q Hong","year":"2024","unstructured":"Hong Q, Chang RYK, Assafiri O, Morales S, Chan HK (2024) Optimizing in vitro phage-ciprofloxacin combination formulation for respiratory therapy of multi-drug resistant Pseudomonas aeruginosa infections. Int J Pharm 652:123853","journal-title":"Int J Pharm"},{"issue":"6359","key":"557_CR169","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aan8630","volume":"358","author":"L Xu","year":"2017","unstructured":"Xu L, Pegu A, Rao E, Doria-Rose N, Beninga J, McKee K et\u00a0al (2017) Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques. Science 358(6359):85\u201390","journal-title":"Science"},{"issue":"5","key":"557_CR170","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmi.2018.08.004","volume":"25","author":"SO Ali","year":"2019","unstructured":"Ali SO, Yu XQ, Robbie GJ, Wu Y, Shoemaker K, Yu L, DiGiandomenico A, Keller AE, Anude C, Hernandez-Illas M, Bellamy T, Falloon J, Dubovsky F, Jafri HS (2019) Phase 1 study of MEDI3902, an investigational anti\u2013Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults. Clin Microbiol Infect 25(5):629-e1","journal-title":"Clin Microbiol Infect"},{"issue":"262","key":"557_CR171","doi-asserted-by":"publisher","first-page":"262ra155","DOI":"10.1126\/scitranslmed.3009655","volume":"6","author":"A DiGiandomenico","year":"2014","unstructured":"DiGiandomenico A, Keller AE, Gao C, Rainey GJ, Warrener P, Camara MM, Bonnell J, Fleming R, Bezabeh B, Dimasi N, Sellman BR, Hilliard J, Guenther CM, Datta V, Zhao W, Gao C, Yu XQ, Suzich JA, Stover CK (2014) A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci Transl Med 6(262):262ra155-262ra155","journal-title":"Sci Transl Med"},{"key":"557_CR172","volume":"7","author":"SI Mohammad","year":"2024","unstructured":"Mohammad SI, Aldosari BN, Mehanni MM, El-Gendy AO, Hozayen WG, Afzal O, Zaki RM, Sayed OM (2024) Fabrication and application of targeted ciprofloxacin nanocarriers for the treatment of chronic bacterial prostatitis. Int J Pharm X 7:100247","journal-title":"Int J Pharm X"},{"issue":"657","key":"557_CR173","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo7793","volume":"14","author":"MA Cook","year":"2022","unstructured":"Cook MA, Wright GD (2022) The past, present, and future of antibiotics. Sci Transl Med 14(657):eabo7793","journal-title":"Sci Transl Med"},{"key":"557_CR174","doi-asserted-by":"crossref","unstructured":"Hey A (2015) History and practice: antibodies in infectious diseases. Antibodies Infect Dis 1\u201321","DOI":"10.1128\/9781555817411.ch1"},{"key":"557_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01379","volume":"10","author":"W Huang","year":"2019","unstructured":"Huang W, Zhang Q, Li W, Chen Y, Shu C, Li Q, Zhou J, Ye C, Bai H, Sun W, Yang S, Ma Y (2019) Anti-outer membrane vesicle antibodies increase antibiotic sensitivity of pan-drug-resistant Acinetobacter baumannii. Front Microbiol 10:1379","journal-title":"Front Microbiol"},{"issue":"8","key":"557_CR176","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10096-011-1509-2","volume":"31","author":"Y Song","year":"2012","unstructured":"Song Y, Baer M, Srinivasan R, Lima J, Yarranton G, Bebbington C, Lynch SV (2012) PcrV antibody\u2013antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice. Eur J Clin Microbiol Infect Dis 31(8):1837\u20131845","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Topics in Current Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41061-026-00557-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41061-026-00557-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41061-026-00557-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:03:16Z","timestamp":1789005796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41061-026-00557-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":176,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1007\/s41061-026-00557-9","relation":{},"ISSN":["2364-8961"],"issn-type":[{"value":"2364-8961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informal Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22"}}